BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24337374)

  • 1. Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations.
    Le Page ME; Goodridge JP; John E; Christiansen FT; Witt CS
    J Immunol; 2014 Jan; 192(2):732-40. PubMed ID: 24337374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to comment on "killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations".
    Le Page ME; Goodridge JP; John E; Christiansen FT; Witt CS
    J Immunol; 2014 May; 192(9):4003-4. PubMed ID: 24748632
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on "Killer Ig-like receptor 2DL4 does not mediate NK Cell IFN-γ responses to soluble HLA-G preparations".
    Rajagopalan S; Long EO
    J Immunol; 2014 May; 192(9):4003. PubMed ID: 24748631
    [No Abstract]   [Full Text] [Related]  

  • 4. Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells.
    Gros F; Cabillic F; Toutirais O; Maux AL; Sebti Y; Amiot L
    Eur J Immunol; 2008 Mar; 38(3):742-9. PubMed ID: 18266268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
    Kurago ZB; Lutz CT; Smith KD; Colonna M
    J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible roles of KIR2DL4 expression on uNK cells in human pregnancy.
    Yan WH; Lin A; Chen BG; Zhou MY; Dai MZ; Chen XJ; Gan LH; Zhu M; Shi WW; Li BL
    Am J Reprod Immunol; 2007 Apr; 57(4):233-42. PubMed ID: 17362384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β2-Microglobulin-free HLA-G activates natural killer cells by increasing cytotoxicity and proinflammatory cytokine production.
    Zhao L; Purandare B; Zhang J; Hantash BM
    Hum Immunol; 2013 Apr; 74(4):417-24. PubMed ID: 23228393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIR2DL4-HLAG interaction at human NK cell-oligodendrocyte interfaces regulates IFN-γ-mediated effects.
    Banerjee PP; Pang L; Soldan SS; Miah SM; Eisenberg A; Maru S; Waldman A; Smith EA; Rosenberg-Hasson Y; Hirschberg D; Smith A; Ablashi DV; Campbell KS; Orange JS
    Mol Immunol; 2019 Nov; 115():39-55. PubMed ID: 30482463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
    J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction.
    Spaggiari GM; Contini P; Dondero A; Carosio R; Puppo F; Indiveri F; Zocchi MR; Poggi A
    Blood; 2002 Dec; 100(12):4098-107. PubMed ID: 12393468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
    Morel E; Bellón T
    J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.
    Schleicher U; Liese J; Knippertz I; Kurzmann C; Hesse A; Heit A; Fischer JA; Weiss S; Kalinke U; Kunz S; Bogdan C
    J Exp Med; 2007 Apr; 204(4):893-906. PubMed ID: 17389237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition.
    Yan WH; Fan LA
    Cell Res; 2005 Mar; 15(3):176-82. PubMed ID: 15780179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production.
    Kikuchi-Maki A; Yusa S; Catina TL; Campbell KS
    J Immunol; 2003 Oct; 171(7):3415-25. PubMed ID: 14500636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
    Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
    Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genotype of the NK cell receptor, KIR2DL4, influences INFgamma secretion by decidual natural killer cells.
    Goodridge JP; Lathbury LJ; John E; Charles AK; Christiansen FT; Witt CS
    Mol Hum Reprod; 2009 Aug; 15(8):489-97. PubMed ID: 19509110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion.
    Ueshima C; Kataoka TR; Hirata M; Furuhata A; Suzuki E; Toi M; Tsuruyama T; Okayama Y; Haga H
    Cancer Immunol Res; 2015 Aug; 3(8):871-80. PubMed ID: 25735953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of NK cells by an endocytosed receptor for soluble HLA-G.
    Rajagopalan S; Bryceson YT; Kuppusamy SP; Geraghty DE; van der Meer A; Joosten I; Long EO
    PLoS Biol; 2006 Jan; 4(1):e9. PubMed ID: 16366734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.